E-LIB Suche - Ergebnisse für: Soelberg-Sorensen, Per

1

Réduction du risque de progression en sclérose en plaques s..:

Vermersch, Patrick ; Giovannoni, Gavin ; Soelberg-Sorensen, Per...
Revue Neurologique. 176 (2020) - p. S78-S79 , 2020

Link: https://doi.org/10.1016/..

2

Numération des cellules immunitaires innées chez les patien..:

Soelberg-Sorensen, Per ; Dangond, Fernando ; Hicking, Christine.
Revue Neurologique. 174 (2018) - p. S96 , 2018

Link: https://doi.org/10.1016/..

3

Durable efficacy of cladribine tablets in patients with mul..:

Soelberg-Sorensen, Per ; Giovannoni, Gavin ; Comi, Giancarlo...
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..

4

Absolute lymphocyte count recovery in patients with relapsi..:

Soelberg-Sorensen, Per ; Dangond, Fernando ; Hicking, Christine.
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..

5

Defining High Disease Activity (HDA) in Patients with Relap..:

Giovannoni, Gavin ; Rammohan, Kottil ; Cook, Stuart...
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..

6

Efficacy of Cladribine Tablets 3.5 mg/kg in High Disease Ac..:

Giovannoni, Gavin ; Rammohan, Kottil ; Cook, Stuart...
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..

7

Parkinson's Disease in Multiple Sclerosis - A Population-Ba..:

Thormann, Anja ; Magyari, Melinda ; Koch-Henriksen, Nils..
Neurology. 86 (2016) 16_supplement - p. , 2016

Link: https://doi.org/10.1212/..

8

Safety and Efficacy of Oral Cladribine in Patients with Rel..:

Giovannoni, Gavin ; Comi, Giancarlo ; Cook, Stuart...
Neurology. 80 (2013) 7_supplement - p. , 2013

Link: https://doi.org/10.1212/..

9

Immunogenicity of Alemtuzumab Treatment in Relapsing-Remitt..:

Soelberg-Sorensen, Per ; Arnold, Douglas ; Cohen, Jeffrey...
Neurology. 80 (2013) 7_supplement - p. , 2013

Link: https://doi.org/10.1212/..

10

Age-corrected neurofilament light chain ratio decreases but..:

Højsgaard Chow, Helene ; Petersen, Eva Rosa ; Olsson, Anna...
Multiple Sclerosis and Related Disorders. 88 (2024) - p. 105701 , 2024

Link: https://doi.org/10.1016/..

11

Effect of cladribine tablets on lymphocyte reduction and re..:

Comi, Giancarlo ; Cook, Stuart ; Giovannoni, Gavin...
10.1016/j.msard.2019.01.038. , 2023

Link: https://hdl.handle.net/2..

12

Population Pharmacokinetic–B Cell Modeling for Ofatumumab i..:

Yu, Huixin ; Graham, Gordon ; David, Olivier J....
CNS Drugs. 36 (2022) 3 - p. 283-300 , 2022

Link: https://doi.org/10.1007/..

13

Treatment Switching and Discontinuation Over 20 Years in th..:

Hillert, Jan ; Magyari, Melinda ; Soelberg Sørensen, Per...
Frontiers in Neurology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

14

Predictors of treatment outcome in patients with paediatric..:

Kopp, Tine Iskov ; Blinkenberg, Morten ; Chalmer, Thor Ameri...
Multiple Sclerosis Journal. 26 (2019) 8 - p. 964-975 , 2019

Link: https://doi.org/10.1177/..

15

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a r..:

on behalf of the MESEMS study group ; Uccelli, Antonio ; Laroni, Alice...
Trials. 20 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..